Adenosine receptors as drug targets—what are the challenges?

JF Chen, HK Eltzschig, BB Fredholm - Nature reviews Drug discovery, 2013 - nature.com
Adenosine signalling has long been a target for drug development, with adenosine itself or
its derivatives being used clinically since the 1940s. In addition, methylxanthines such as …

Focusing on adenosine receptors as a potential targeted therapy in human diseases

WI Effendi, T Nagano, K Kobayashi, Y Nishimura - Cells, 2020 - mdpi.com
Adenosine is involved in a range of physiological and pathological effects through
membrane-bound receptors linked to G proteins. There are four subtypes of adenosine …

Adenosine and brain function

BB Fredholm, JF Chen, RA Cunha… - Int Rev …, 2005 - books.google.com
A. Cellular and Subcellular Localization B. Pharmacological Tools to Study Adenosine
Receptors C. Signaling Via Adenosine Receptors D. Regulation of Receptor Expression and …

The neurobiology and control of anxious states

MJ Millan - Progress in neurobiology, 2003 - Elsevier
Fear is an adaptive component of the acute “stress” response to potentially-dangerous
(external and internal) stimuli which threaten to perturb homeostasis. However, when …

Adenosine, an endogenous distress signal, modulates tissue damage and repair

BB Fredholm - Cell Death & Differentiation, 2007 - nature.com
Adenosine is formed inside cells or on their surface, mostly by breakdown of adenine
nucleotides. The formation of adenosine increases in different conditions of stress and …

Extracellular ATP and adenosine: The Yin and Yang in immune responses?

MM Faas, T Sáez, P De Vos - Molecular Aspects of Medicine, 2017 - Elsevier
Abstract Extracellular adenosine 5′-triphosphate (ATP) and adenosine molecules are
intimately involved in immune responses. ATP is mostly a pro-inflammatory molecule and is …

Purinergic signalling: from normal behaviour to pathological brain function

G Burnstock, U Krügel, MP Abbracchio, P Illes - Progress in neurobiology, 2011 - Elsevier
Purinergic neurotransmission, involving release of ATP as an efferent neurotransmitter was
first proposed in 1972. Later, ATP was recognised as a cotransmitter in peripheral nerves …

Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade

RA Cunha - Purinergic signalling, 2005 - Springer
Adenosine is a neuromodulator that operates via the most abundant inhibitory adenosine A
1 receptors (A 1 Rs) and the less abundant, but widespread, facilitatory A 2A Rs. It is …

Physiological roles for ecto-5'-nucleotidase (CD73)

SP Colgan, HK Eltzschig, T Eckle, LF Thompson - Purinergic signalling, 2006 - Springer
Nucleotides and nucleosides influence nearly every aspect of physiology and
pathophysiology. Extracellular nucleotides are metabolized through regulated …

The role of adenosine receptors in mood and anxiety disorders

D van Calker, K Biber, K Domschke… - Journal of …, 2019 - Wiley Online Library
Adenosine receptor subtypes, first described 40 years ago, are known to regulate diverse
biological functions and have a role in various conditions, such as cerebral and cardiac …